NDC 71335-0909

Methocarbamol

Methocarbamol Tablets

Methocarbamol is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Methocarbamol.

Product ID71335-0909_65c460f6-6470-41ff-abb4-d9d54ecc52f7
NDC71335-0909
Product TypeHuman Prescription Drug
Proprietary NameMethocarbamol
Generic NameMethocarbamol Tablets
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2018-07-02
Marketing CategoryANDA / ANDA
Application NumberANDA209312
Labeler NameBryant Ranch Prepack
Substance NameMETHOCARBAMOL
Active Ingredient Strength750 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71335-0909-0

14 TABLET, COATED in 1 BOTTLE (71335-0909-0)
Marketing Start Date2021-12-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0909-1 [71335090901]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-3 [71335090903]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-2 [71335090902]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-4 [71335090904]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-5 [71335090905]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-7 [71335090907]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-9 [71335090909]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-8 [71335090908]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-6 [71335090906]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

NDC 71335-0909-0 [71335090900]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-07-31

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL750 mg/1

OpenFDA Data

SPL SET ID:65c460f6-6470-41ff-abb4-d9d54ecc52f7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197943
  • 197944

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Methocarbamol" or generic name "Methocarbamol Tablets"

    NDCBrand NameGeneric Name
    0143-1290MethocarbamolMethocarbamol
    0143-1292MethocarbamolMethocarbamol
    0179-0092MethocarbamolMethocarbamol
    0276-0510MethocarbamolMethocarbamol
    0404-9909MethocarbamolMethocarbamol
    0440-1740Methocarbamolmethocarbamol
    0517-1825Methocarbamolmethocarbamol
    0603-4485Methocarbamolmethocarbamol
    0603-4486Methocarbamolmethocarbamol
    0615-7572Methocarbamolmethocarbamol
    0615-7573Methocarbamolmethocarbamol
    0615-8435METHOCARBAMOLMETHOCARBAMOL
    0615-8436METHOCARBAMOLMETHOCARBAMOL
    0904-7057MethocarbamolMethocarbamol
    0904-7058MethocarbamolMethocarbamol
    10135-664MethocarbamolMethocarbamol
    10135-665MethocarbamolMethocarbamol
    10544-259MethocarbamolMethocarbamol
    10544-464MethocarbamolMethocarbamol
    10544-622MethocarbamolMethocarbamol
    10544-773MethocarbamolMethocarbamol
    10544-956Methocarbamolmethocarbamol
    17511-505METHOCARBAMOLMETHOCARBAMOL
    17511-506METHOCARBAMOLMETHOCARBAMOL
    21695-078MethocarbamolMethocarbamol
    21695-079MethocarbamolMethocarbamol
    68071-1874MethocarbamolMethocarbamol
    68071-4365MethocarbamolMethocarbamol
    68071-4458MethocarbamolMethocarbamol
    68071-4505MethocarbamolMethocarbamol
    68083-317MethocarbamolMethocarbamol
    68084-056MethocarbamolMethocarbamol
    68071-4520MethocarbamolMethocarbamol
    68084-057MethocarbamolMethocarbamol
    68151-2775MethocarbamolMethocarbamol
    68387-340MethocarbamolMethocarbamol
    68387-342MethocarbamolMethocarbamol
    68475-002MethocarbamolMethocarbamol
    68788-6391MethocarbamolMethocarbamol
    68788-9076MethocarbamolMethocarbamol
    68788-9075MethocarbamolMethocarbamol
    68788-9388MethocarbamolMethocarbamol
    68788-9768MethocarbamolMethocarbamol
    68788-9376MethocarbamolMethocarbamol
    69543-134MethocarbamolMethocarbamol
    69543-135MethocarbamolMethocarbamol
    70010-754MethocarbamolMethocarbamol
    70069-101MethocarbamolMethocarbamol
    70010-770MethocarbamolMethocarbamol
    70518-0024MethocarbamolMethocarbamol
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.